Dupixent approved in Japan for bullous pemphigoid treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. USO
7. LAES
8. FUL
9. AAPL
10. IBM

Go back to Dupixent approved in Japan for bullous pemphigoid treatment
Regeneron (NASDAQ: REGN) Delayed: 625.07 +1.64 (0.26%)
Previous Close $623.43    52 Week High $592.36 
Open $623.16    52 Week Low $325.35 
Day High $634.31    P/E 164.06 
Day Low $623.16    EPS $3.81 
Volume 341,416